SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 111.97   2.18 (+1.99%) Volume: 232.45k 4:00 PM EDT Jul 8, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
S-3Registration statement under Securities Act of 1933404/29/2002
ARSAnnual Report to Security Holders104/22/2002
DEF 14AOther definitive proxy statements104/12/2002
8-KCurrent report pursuant to Section 13 or 15(d)204/12/2002
8-KCurrent report pursuant to Section 13 or 15(d)204/12/2002
8-KCurrent report pursuant to Section 13 or 15(d)104/04/2002
8-KCurrent report pursuant to Section 13 or 15(d)304/02/2002
8-KCurrent report pursuant to Section 13 or 15(d)304/02/2002
SC 13D/A[Amend] General statement of acquisition of beneficial ownership103/22/2002
10-KAnnual report pursuant to Section 13 or 15(d)7803/19/2002
10-KAnnual report pursuant to Section 13 or 15(d)7803/19/2002
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/14/2002
SC 13GStatement of acquisition of beneficial ownership by individuals302/13/2002
SC 13GStatement of acquisition of beneficial ownership by individuals302/13/2002
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/11/2002
102103104105106107108109110111112113114115116